List of works by Laurence Albiges

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A Case of Heavily Pretreated Metastatic Germ Cell Tumor With Ongoing Long-term Complete Response After Gemcitabine Treatment

scientific article published on 26 January 2019

A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human

scientific article published on 07 September 2018

A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma.

scientific article

A new prognostic model for survival in second line for metastatic renal cell carcinoma: development and external validation

scientific article published on 09 February 2019

A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in France

scientific article published on 10 February 2017

A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer

scientific article

Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen.

scientific article published on 22 February 2012

Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study

scientific article published on 27 June 2020

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

scientific article

Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy

scientific article published in March 2017

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial

scientific article published on 20 November 2015

Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer

scientific article published on 11 April 2017

Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100).

scientific article published on 10 April 2013

Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study

scientific article published on 09 July 2020

Assessment of Early Tumour Shrinkage: Ready for Integration in the Treatment Strategy for Metastatic Renal Cell Carcinoma?

scientific article published on 5 August 2016

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

scientific article published on 16 February 2019

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

scientific article published on 07 September 2020

Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial

scientific article published on 05 March 2020

Axitinib in metastatic renal cell carcinoma

scientific article published on May 2015

Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events

scientific article published on 26 June 2020

Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer

scientific article

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

scientific article

Burned-Out Testis Tumors in Asymptomatic Infertile Men: Multiparametric Sonography and MRI Findings.

scientific article

Cabozantinib for the treatment of renal cell carcinoma

scientific article published on 11 November 2016

Cancer du rein : tendances et perspectives

scientific article published on 01 December 2018

Cessation of vascular endothelial growth factor-targeted therapy in patients with metastatic renal cell carcinoma: feasibility and clinical outcome

scientific article published on 02 December 2011

Characterization of Testicular Masses in Adults: Performance of Combined Quantitative Shear Wave Elastography and Conventional Ultrasound

scientific article published on 29 December 2018

Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature

scientific article published on 10 September 2016

Chk1 as a new therapeutic target in triple-negative breast cancer

scientific article published on 15 March 2014

Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trials

scientific article published on 13 May 2013

Clinical implications of body composition assessment by computed tomography in metastatic renal cell carcinoma

scientific article published on 09 January 2014

Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab

scientific article published on 07 February 2019

Complete remission with tyrosine kinase inhibitors in renal cell carcinoma.

scientific article

Compliance with guidelines and correlation with outcome in patients with advanced germ-cell tumours

scientific article published on 20 February 2014

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

scientific article published on 4 November 2015

Corrigendum to "Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours" [Eur J Cancer 69 (2016) 151-157]

scientific article published on 07 March 2017

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

scientific article published on 14 November 2017

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

scientific article published on 01 August 2020

Current and future strategies in nonclear-cell metastatic renal cell carcinoma

scientific article published on September 2015

Current role of cabozantinib in metastatic castration-resistant prostate cancer

scientific article

Current role of diethylstilbestrol in the management of advanced prostate cancer

scientific article published on 11 May 2012

Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study

article

Diagnosis of Renal Cell Carcinoma: A Clinician's Perspective

scientific article

Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma

scientific article

Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression

scientific article published on 23 October 2017

Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma.

scientific article published on 12 January 2017

Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors

scientific article published on 4 January 2018

ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis

scientific article published on 2 November 2017

Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial

scientific article published on 29 May 2020

Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma.

scientific article

Emerging tyrosine kinase inhibitors for the treatment of renal cancer

scientific article published on 18 May 2015

Erratum to 'Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma' [Eur J Cancer 108 (February 2019) 33-40]

scientific article published on 11 July 2019

Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase 2 study

scientific article published on 20 November 2018

Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave Roussy

scientific article published on 12 August 2017

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

scientific article published on 25 November 2015

Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: results of a pooled analysis of non-interventional studies

scientific article published on 11 August 2015

Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell Carcinoma

scientific article published on 6 November 2014

False positive 2-(18)Fluroro-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with disseminated seminoma and post-chemotherapy residual masses

scientific article published on 13 September 2012

Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

scientific article published on 03 May 2020

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

scientific article published on 2 November 2017

Haematological complications of prostatic cancer: 2 cases, one revealing the neoplasia

scientific article

Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic

scientific article published on 06 July 2018

High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting

scientific article published on 13 August 2015

How to select amongst available options for the treatment of advanced RCC?

scientific article published in September 2012

How to select targeted therapy in renal cell cancer

scientific article published on October 2010

Hypertension and Angiotensin System Inhibitors in Patients with Metastatic Renal Cell Carcinoma

scientific article

Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma

scientific article published on 20 March 2015

ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy

scientific article published on 8 October 2014

Imaging in Suspected Renal-Cell Carcinoma: Systematic Review

scientific article published on 11 August 2018

Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma

scientific article published on 01 September 2018

Immunodynamics of explanted human tumors for immuno-oncology

scientific article published on 29 December 2020

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

scientific article published on 11 May 2016

Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma

scientific article published on 29 June 2020

Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.

scientific article published on 8 August 2016

Kikuchi disease and lupus: case report, literature review and FDG PET/CT interest

scientific article published on 14 July 2011

Les métastases cérébrales de cancer du rein, un défi clinique

scientific article published on 01 December 2018

Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel

scientific article published on 31 March 2020

Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome

scientific article published on 06 March 2020

Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes

scientific article

Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome

scientific article published on 5 March 2015

Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial

scientific article published on 07 April 2020

Long-term Efficacy and Safety Results: Can Enzalutamide Challenge the Dogma of Androgen Deprivation Therapy in Hormone-naïve Prostate Cancer?

scientific article published on 24 April 2015

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients

scientific article

MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array

scientific article published on 21 March 2014

Management of Metastatic Nonclear-Clear Cell Renal Cell Carcinoma: What Are the Oare the options and Challenges?

scientific article published on 15 June 2020

Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel

scientific article published on 04 June 2019

Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?

scientific article published on 19 July 2019

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study ⬇️

scientific article published on 23 May 2017

Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography

scientific article published on 9 February 2010

Metastatic tumors to the colon and rectum: a multi-institutional study

scientific article published in November 2012

Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma

scientific article

Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model

scientific article published on 20 February 2017

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

scientific article published on February 2016

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small cell lung cancer.

scientific article published on 30 March 2018

Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives

scientific article published on December 2012

New drugs in metastatic castration-resistant prostate cancer

scientific article published in January 2010

Nivolumab in renal cell carcinoma: latest evidence and clinical potential

scientific article published on 11 December 2016

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial

scientific article published on 01 November 2020

Non-Clear Cell Renal Cell Carcinomas: From Shadow to Light

scientific article published on 29 October 2018

Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?

scientific article

Nonfamilial Chronic Serum Alpha-Fetoprotein Increase in a Patient With Clinical Stage I Seminoma

scientific article published on 17 August 2015

ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer

scientific article

Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy

scientific article published on 27 February 2017

Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis

scientific article published on 24 September 2016

Optimal management of metastatic renal cell carcinoma: current status

scientific article published on April 2013

PD-L1 expression in nonclear-cell renal cell carcinoma

scientific article

Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.

scientific article published on 6 August 2016

Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone

scientific article published on 18 October 2016

Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours

scientific article

Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets

scientific article

Prevalence and causes of burnout amongst oncology residents: a comprehensive nationwide cross-sectional study

scientific article

Primitive neuroectodermal tumor of the myometrium with cardio-vascular symptoms

scientific article published on 23 July 2007

Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancer

scientific article

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

scientific article published on 06 July 2021

Radiologic Heterogeneity in Responses to Anti-PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma

scientific article published on 20 November 2015

Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre

scientific article published on 13 May 2017

Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase I trials.

scientific article published on 21 April 2011

Recommendations for the Management of Rare Kidney Cancers

scientific article published on 15 July 2017

Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status

scientific article published on 17 December 2015

Renal Cell Carcinoma with bone metastases isn't always bad

scientific article published on 16 July 2019

Renal cell carcinoma

scientific article

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population

scientific article published on 2 March 2011

Renal-cell carcinoma in 2016: Advances in treatment - jostling for pole position

scientific article published on 10 January 2017

Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers

scientific article published on 3 July 2013

Reversible posterior leukoencephalopathy syndrome induced by axitinib.

scientific article

Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell

scientific article published on 05 November 2015

Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study

scientific article published on 13 June 2019

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

scientific article published on 10 January 2018

Safety of available treatment options for renal cell carcinoma

scientific article published on 4 May 2016

Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients.

scientific article published on 13 March 2013

Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma

scientific article published on 05 January 2019

Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma

scientific article published on 01 August 2019

Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies

scientific article

Smoking and Disease Outcomes in Patients With Malignant Germ Cell Tumors

scientific article published on 3 August 2017

Sorafenib-Sunitinib Sequence: The Jury Is Out.

scientific article published on 13 July 2015

Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases

scientific article published on 21 June 2005

Statins and survival outcomes in patients with metastatic renal cell carcinoma

scientific article published on 11 December 2015

Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group

scientific article published on 01 June 2018

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

scientific article published on 03 June 2018

Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial

scientific article published on 30 July 2018

Survey of the Impact of COVID-19 on Oncologists' Decision Making in Cancer

scientific article published on 01 August 2020

Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma

scientific article published on 25 October 2018

Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions

article

Testicular ultrasensitive Doppler preliminary experience: a feasibility study.

scientific article published in January 2017

Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC)

article by Edoardo Francini et al published September 2018 in The Prostate

Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report

scientific article published on 02 April 2020

Traitement des métastases osseuses du cancer du rein

scientific article published on 01 December 2018

Trastuzumab treatment in t1ab, node-negative, human epidermal growth factor receptor 2-overexpressing breast carcinomas

scientific article

Treating patients with renal cell carcinoma and bone metastases

scientific article published on 13 September 2018

Trends in the practice of renal surgery for cancer in France after the introduction of robotic-assisted surgery: data from the National Health Care System Registry

scientific article published on 30 April 2020

Tumor growth rate provides useful information to evaluate sorafenib and everolimus treatment in metastatic renal cell carcinoma patients: an integrated analysis of the TARGET and RECORD phase 3 trial data

scientific article

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma

scientific article published on 04 March 2014

Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma

scientific article published on 26 October 2012

Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma

scientific article published on 18 March 2020

Updated European Association of Urology Guidelines Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer

scientific article

Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma.

scientific article published on 13 December 2016

Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma

scientific article published on 31 August 2018

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

scientific article published on 01 August 2019

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma

scientific article published on 24 April 2020

Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma

scientific article published on August 2011

Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinoma

scientific article published on June 2011

Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma

scientific article published on 09 October 2019

Welcome to European Urology Oncology: Your New Journal, Where Multiple Disciplines Meet To Improve Care of Patients with Genitourinary Cancers

scientific article published on 15 May 2018

Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma

scientific article published on July 2016

Why do residents choose the medical oncology specialty? Implications for future recruitment--results of the 2007 French Association of Residents in Oncology (AERIO) Survey

scientific article

[Axitinib in metastatic renal carcinomas: update of knowledge about side effects].

scientific article published in October 2014

[Testicular tumors: A diagnostic challenge of imaging]

scientific article published on 12 May 2019

Paulina is supported by:

About Paulina

Help